P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience

• D. Nasikas,
• F. Fostira,
• N. Tsoulos,
• A. Fokianou,
• P. Kontogianni,
• P. Ntasiou,
• G. Xepapadakis

Affiliations

D. Nasikas

F. Fostira

N. Tsoulos

A. Fokianou

P. Kontogianni

P. Ntasiou

G. Xepapadakis